Rationale: Epidemiological studies demonstrate a clear association of adverse intrauterine environment with an increased risk of ischemic heart disease in adulthood. Hypoxia is a common stress to the fetus and results in decreased protein kinase C epsilon (PKC) expression in the heart and increased cardiac vulnerability to ischemia and reperfusion injury in adult offspring in rats. Objectives: The present study tested the hypothesis that fetal hypoxia-induced methylation of cytosine-phosphateguanine dinucleotides at the PKC promoter is repressive and contributes to PKC gene repression in the heart of adult offspring. Methods and Results: Hypoxic treatment of pregnant rats from days 15 to 21 of gestation resulted in significant decreases in PKC protein and mRNA in fetal hearts. Similar results were obtained in ex vivo hypoxic treatment of isolated fetal hearts and rat embryonic ventricular myocyte cell line H9c2. Increased methylation of PKC promoter at SP1 binding sites, ؊346 and ؊268, were demonstrated in both fetal hearts of maternal hypoxia and H9c2 cells treated with 1% O 2 for 24 hours. Whereas hypoxia had no significant effect on the binding affinity of SP1 to the unmethylated sites in H9c2 cells, hearts of fetuses and adult offspring, methylation of both SP1 sites reduced SP1 binding. The addition of 5-aza-2-deoxycytidine blocked the hypoxia-induced increase in methylation of both SP1 binding sites and restored PKC mRNA and protein to the control levels. In hearts of both fetuses and adult offspring, hypoxia-induced methylation of SP1 sites was significantly greater in males than in females, and decreased PKC mRNA was seen only in males. In fetal hearts, there was significantly higher abundance of estrogen receptor ␣ and ␤ isoforms in females than in males. Both estrogen receptor ␣ and ␤ interacted with the SP1 binding sites in the fetal heart, which may explain the sex differences in SP1 methylation in the fetal heart. Additionally, selective activation of PKC restored the hypoxia-induced cardiac vulnerability to ischemic injury in offspring. Conclusions: The findings demonstrate a direct effect of hypoxia on epigenetic modification of DNA methylation and programming of cardiac PKC gene repression in a sex-dependent manner, linking fetal hypoxia and pathophysiological consequences in the hearts of adult offspring. (Circ Res. 2010;107:00-00.)
H eart disease is the leading cause of death in the United
States. In addition to other risk factors, recent epidemiological and animal studies have shown a clear association of adverse intrauterine environment with an increased risk of hypertension and ischemic heart disease in adulthood. [1] [2] [3] [4] Hypoxia is a common form of intrauterine stress, and the fetus may experience prolonged hypoxic stress under a variety of conditions, including pregnancy at high altitude, pregnancy with anemia, placental insufficiency, cord compression, preeclampsia, heart, lung and kidney disease, or with hemoglobinopathy. Animal studies suggest a possible link between fetal hypoxia and increased risk of cardiovascular disease in offspring. [5] [6] [7] [8] [9] [10] [11] [12] [13] Studies in rats have demonstrated that maternal hypoxia results in an increase in cardiac vulnerability to ischemia and reperfusion injury in male offspring. 10, 14, 15 In addition, it has been demonstrated that downregulation of protein kinase C epsilon (PKC) protein expression in the hearts of adult offspring is a mechanism for the increased heart susceptibility to ischemia and reperfusion injury in the animals exposed to hypoxia before birth. 14 Among other mechanisms, PKC plays a pivotal role of cardioprotection in heart ischemia and reperfusion injury. 16 -18 The study in a PKC knock-out mouse model has demonstrated that PKC expression is not required for cardiac function under normal physiological conditions, but PKC activation is necessary for acute cardioprotection during cardiac ischemia and reperfusion. 19 The finding that fetal hypoxia resulted in a decrease in PKC protein expression in the heart of adult offspring 10, 14 suggests that an epigenetic mechanism may explain PKC gene repression in the heart. Epigenetic mechanisms are essential for development and differentiation and allow an organism to respond to the environment through changes in gene expression patterns. 20 -22 DNA methylation is a chief mechanism for epigenetic modification of gene expression patterns and occurs at cytosines in the cytosine-phosphate-guanine (CpG) dinucleotide sequence. 23 Methylation in promoter regions is generally associated with repression of transcription, leading to a long-term shutdown of the associated gene. Methylation of CpG islands in gene promoter regions alters chromatin structure and transcription. Similarly, methylation of CpG dinucleotides within transcription factor binding sites generally represses transcription. 20, 24, 25 The present study tested the hypothesis that fetal hypoxia-induced methylation of CpG dinucleotides at the PKC promoter contributes to PKC gene repression in the heart of adult offspring. Herein, we present evidence that hypoxia has a direct effect on PKC expression in the fetal heart and demonstrate in a cell model that hypoxia causes an increase in methylation of CpG dinucleotides at the proximal promoter region of PKC gene, resulting in decreased binding of sequence-specific transcription factors to the promoter and reduced PKC gene expression.
Methods
An expanded Methods section is available in the online Data Supplement at http://circres.ahajournals.org.
Experimental Animals
Pregnant rats were randomly divided into 2 groups: (1) normoxic control and (2) hypoxic treatment of 10.5% O 2 from days 15 to 21 of gestation. 14 Hearts were isolated from near-term (21-day) fetuses and 3-month-old offspring. To study the direct effect of hypoxia on the fetal heart, hearts were isolated from day 17 fetal rats and cultured at 37°C in 95% air/5% CO 2 and 1% O 2 for 48 hours, as reported previously. 24 
Cell Culture
H9c2 cells were grown and subcultured and experiments were performed at 70% to 80% confluent. For hypoxic studies, cells were treated with 1%, 3%, or 10.5% O 2 , respectively, for 24 hours.
Western Blot Analysis
Protein abundance of PKC, specificity protein 1 (SP1), alpha (ER␣), and beta (ER␤) subtypes of estrogen receptors in H9c2 cells and hearts of fetuses and adult offspring were measured with Western blot analysis and were normalized to ␤2-microglobulin (B2 mol/L), as described previously. 25, 26 Real-Time RT-PCR PKC mRNA abundance in H9c2 cells and hearts of fetuses and adult offspring was determined by real-time RT-PCR and was normalized to B2 mol/L. 25, 26 Quantitative Methylation-Specific PCR DNA collected from H9c2 cells and hearts of fetuses and adult offspring was treated with sodium bisulfite at 55°C for 16 hours. Bisulfite-treated DNA was used as a template for real-time fluorogenic methylation-specific PCR using primers created to amplify promoter binding sites containing possible methylation sites based on our previous sequencing of rat PKC promoter. 25 
Electrophoretic Mobility Shift Assay
Nuclear extracts were collected from H9c2 cells and hearts of fetuses and adult offspring. Electrophoretic mobility shift assay (EMSA) was performed using the oligonucleotide probes with either CpG or m CpG in the 2 SP1 binding sites (Ϫ346 and Ϫ268) at rat PKC promoter region, as described previously. 25 
Chromatin Immunoprecipitation
Chromatin extracts were prepared from H9c2 cells and fetal hearts. Chromatin immunoprecipitation (ChIP) assays were performed for the 2 SP1 binding sites at the PKC promoter in DNA sequences pulled down by SP1, ER␣, and ER␤ antibodies. 25 
Hearts Subjected to Ischemia and Reperfusion
Isolated hearts from 3-month-old male offspring were subjected to 20 minutes of global ischemia followed by 30 minutes of reperfusion in the absence or presence of a PKC activator peptide -RACK (0.5 mol/L, KAE-1, KAI Pharmaceuticals) in a Langendorff preparation, as previously described. 14, 27 Postischemic recovery of left ventricular function and lactate dehydrogenase release were determined. 14 
Statistical Analysis
Data are expressed as meansϮSEM. Statistical significance (PϽ0.05) was determined by ANOVA followed by Neuman-Keuls post hoc testing or Student t test, where appropriate.
Results

Effect of Hypoxia on PKC Protein and mRNA in Fetal Cardiomyocytes
Maternal hypoxia resulted in significant decreases in both protein and mRNA abundance of PKC in fetal rat hearts ( Figure 1A ). Similar findings were obtained in isolated fetal hearts treated ex vivo with 1% O 2 ( Figure 1A) , demonstrating a direct effect of hypoxia on PKC expression in the heart. Further study demonstrated in rat embryonic ventricular myocyte cell line H9c2 that 1% O 2 but not 3% or 10.5% O 2 significantly decreased PKC mRNA and protein levels as compared with 21% O 2 ( Figure 1B ).
Methylation of SP1 Binding Sites at the PKC Promoter
Eight putative transcription binding sites containing CpG dinucleotides at rat PKC promoter were previously identified. 25 Treatment of H9c2 cells with 1% O 2 for 24 hours resulted in a significant increase in methylation of SP1 binding sites at Ϫ346 and Ϫ268 but decreased methylation of metal regulatory transcription factor 1 (MTF1) binding site at (Figure 2 ). Hypoxia did not change significantly the methylation status of class B basic helix-loop-helix protein 2, peroxisome proliferatoractivated receptor-␥, E2F transcription factor (E2F), early growth response protein 1 (Egr1), and MTF1 at Ϫ603. Consistent with the findings in H9c2 cells, maternal hypoxic treatment revealed a similar pattern of increased methylation of the 2 SP1 binding sites, Ϫ346 and Ϫ268, at the PKC promoter in the fetal hearts ( Figure 2 ). In addition, in vivo hypoxia resulted in an increase in methylation of the putative Egr1 binding site in the fetal heart ( Figure 2 ).
Methylation Inhibits SP1 Binding
H9c2 cells were used to further determine the role of methylation in PKC downregulation. Given the previous finding that deletions of the regions containing the putative Egr1 site and MTF1 site at Ϫ168 had no significant effects on the PKC promoter activity, 25 our further investigation focused on the 2 SP1 binding sites. SP1 binding and the functional significance of the SP1 binding sites in the regulation of PKC gene activity was demonstrated previously. 25 To determine if methylation of the SP1 sites inhibits SP1 binding from nuclear extracts of H9c2 cells, EMSA was performed with methylated and unmethylated oligonucleotide probes containing the SP1 sites at Ϫ346 and Ϫ268. As shown in Figure 3 , nuclear extracts from H9c2 cells bound and shifted the double-stranded unmethylated SP1 oligonucleotides at both sites but failed to cause a shift of the methylated SP1 oligonucleotides. This is consistent with the previous findings in fetal rat hearts showing a loss of binding of the nuclear extracts to the methylated SP1 oligonucleotides. 24 
Effect of Hypoxia on SP1 Abundance and Binding Affinity
Western blots revealed that hypoxia caused a significant increase in nuclear SP1 abundance in H9c2 cells (Online Figure I ). In contrast, there was no significant difference in SP1 abundance either in fetal hearts between control and maternal hypoxic treatments or in the hearts of both male and female offspring between the control and prenatally hypoxic animals (Online Figure I ). The binding affinity of SP1 to the unmethylated SP1 binding sites was determined in competition studies performed in pooled nuclear extracts with the increasing ratio of unlabeled/labeled oligonucleotides encompassing the SP1 sites at Ϫ346 and Ϫ268, respectively. Hypoxia had no significant effect on the binding of nuclear extracts to either SP1 sites at Ϫ346 or Ϫ268 in H9c2 cells, fetal hearts, or the hearts of both male and female offspring (Online Figure II) .
Inhibition of DNA Methylation Restored PKC Expression
To determine the causal role of CpG dinucleotide methylation in the downregulation of PKC expression, we exposed H9c2 cells to 1% O 2 in the absence or presence of increasing concentrations of the DNA methylation inhibitor 5-aza-2Ј-deoxycytodine. As shown in Figure 4 , 5-aza-2Ј-deoxycytodine produced a concentration-dependent inhibition of hypoxiainduced decrease in PKC mRNA and 30 mol/L 5-aza-2Ј-deoxycytodine restored the mRNA to normoxic levels. This was accompanied by restoration of PKC protein ( Figure 4 ). The inhibition of hypoxia-induced methylation of the 2 SP1 binding sites by 5-aza-2Ј-deoxycytodine was demonstrated ( Figure 5A ).
To confirm that hypoxia-induced methylation alters SP1 binding to the PKC promoter in the context of intact chromatin, ChIP assays were performed using a SP1 antibody. Figure 5B shows that hypoxia caused significant decreases in the SP1 binding to both SP1 sites at Ϫ346 and Ϫ268, respectively, in H9c2 cells. However, in the presence of 5-aza-2-deoxycytine, there were no significant differences in SP1 binding to the either sites between hypoxic and normoxic samples ( Figure 5B ).
Sex Differences in Hypoxia-Induced Changes in Methylation and PKC Expression
We further investigated the potential sex differences in hypoxia-induced methylation of the SP1 binding sites and PKC transcription. Maternal hypoxia caused a minimal but significant increase in methylation at both SP1 binding sites in the hearts of female fetuses but induced significantly greater methylation in male fetal hearts ( Figure 6A ). PKC mRNA was significantly decreased in the hearts of male but not female fetuses ( Figure 6B ). The similar pattern of sex differences in the hypoxia-induced SP1 methylation and PKC transcription was demonstrated in the hearts of male and female offspring ( Figure 6A and 6B). The sex difference observed in the fetal hearts was intriguing given that male and female fetuses were probably exposed to the similar concen- trations of steroid hormones in utero. However, both ER␣ and ER␤ abundance was significantly higher in the hearts of female, as compared with male fetuses ( Figure 7A ). Chromatin immunoprecipitation assay demonstrated the PCR products of the two SP1 binding sites in the DNA sequences pulled down by both ER␣ and ER␤ antibodies in the fetal hearts ( Figure 7B ), suggesting an interaction between estrogen receptors and the SP1 binding sites at the PKC promoter.
PKC Activation Restored Hypoxia-Induced Cardiac Vulnerability to Ischemic Injury
The cause-and-effect evidence of the functional importance of PKC in hypoxia-mediated, sex-dependent programming of increased heart vulnerability to ischemia and reperfusion injury in adult male offspring has been previously demonstrated by selective inhibition of PKC with a PKC translocation inhibitor peptide. 14 To further demonstrate that decreased PKC is an important factor in the hypoxiainduced increase in cardiac ischemic susceptibility in male offspring, additional studies were performed in the hearts in a Langendorff preparation using a selective PKC activator peptide -RACK obtained from KAI Pharmaceuticals. 16, [27] [28] [29] There were no significant differences in left ventricular developed pressure, heart rate, dP/dt max , dP/dt min , and coronary flow rate at the baseline among all groups (Online Table I ). In the absence of -RACK, fetal hypoxia caused a significant decrease in postischemic recovery of left ventricular developed pressure and increases in left ventricular end-diastolic pressure and lactate dehydrogenase release (Figure 8 ), as well as decreases in the recovery of dP/dt max and dP/dt min (Online Figure III) , as previously reported. 14 -RACK increased postischemic recovery of left ventricular function, as shown in the previous studies, 27, 29 and abolished the hypoxic effects ( Figure 8 and Online Figure III ).
Discussion
The present study demonstrates that hypoxia has a direct effect on fetal cardiomyocytes causing a reduction in PKC protein and mRNA. This is correlated with increased methylation of CpG dinucleotides in the 2 SP1 binding sites at the proximal promoter region of PKC gene, resulting in decreased binding of SP1 to the promoter. The causal effect of methylation in the hypoxia-induced PKC gene repression is demonstrated through the use of a DNA methylation inhibitor, which blocks the methylation and restores PKC mRNA and protein expression to normal. Previous studies demonstrated the long-term adverse effect of maternal hypoxia on cardiac vulnerability to ischemia and reperfusion injury in adult male offspring in a sex-dependent manner. 10, 14, 15 Particularly, the decreased expression of cardioprotective genes, namely PKC in hearts of adult male offspring are of significant interest. 14 Acute hypoxia and reactive oxygen species increase the activity of PKC in the heart, which plays an important role in cardioprotection during ischemia and reperfusion injury. 30 The present study demonstrated that chronic hypoxia during gestation downregulated PKC expression in the developing heart through an epigenetic modification. This suggests differential regulations of acute hypoxia and chronic hypoxia on PKC activity and gene expression in the heart. The causal role of reduced PKC in sex-dependent programming of increased heart vulnerability to ischemia and reperfusion injury in adult male offspring has been demonstrated by selective inhibition of PKC with a PKC translocation inhibitor peptide. 14, 31 The present study demonstrated that a selective PKC activator peptide 16, [27] [28] [29] restored the hypoxia-induced cardiac vulnerability to ischemic injury, providing further evidence of cause-and-effect role of decreased PKC in the hypoxiamediated, sex-dependent programming of increased heart ischemic vulnerability in male offspring. This is consistent with other studies showing that PKC expression is necessary for acute cardioprotection during cardiac ischemia and reperfusion. 19 The present finding of decreased PKC protein and mRNA in fetal hearts caused by maternal hypoxia suggests that the reduction in PKC expression observed in adult rats 10, 14 originates in utero. Previous studies in the same animal model demonstrated that maternal hypoxia increased hypoxia-inducible factor 1␣ (HIF-1␣) protein in fetal hearts, suggesting tissue hypoxia in the fetal heart. 32 The similar results of isolated hearts treated ex vivo with hypoxia indicate that hypoxia is necessary and sufficient to affect the PKC expression in fetal hearts. Whether this decreased PKC expression in the heart is a protective mechanism that increases fetal survival is not clear at present. However, the finding that the downregulation of PKC resulted in increased heart ischemic vulnerability in offspring would suggest that it is a maladaptive response.
The present study used the embryonic rat ventricular myocyte cell line H9c2 33 to investigate the underlying mechanisms. H9c2 cell line has been widely used in a variety of myocardiocyte studies, including those investigating apoptosis, differentiation and ischemia, and reperfusion injury. 34 -38 H9c2 cells retain many electrophysical properties found in freshly isolated cardiomyocytes, 33 albeit they do not spontaneously contract and are capable of continuous growth. 39 In the present study, the hypoxia-induced decrease in PKC expression observed in fetal hearts in vivo and ex vivo mirrored that found in H9c2 cells, suggesting a congruent underlying mechanism for each model and providing a comparable model of H9c2 cells in the study of PKC gene regulation. Similar to the present finding, it has been reported that PKC protein expression is decreased in H9c2 cells exposed to 2 and 8 hours of hypoxia in the presence of low and high glucose. 40, 41 Another question pertained to normal physiological PKC expression in fetal heart cells. 21% O 2 (147 torr) is generally considered normal for adult cells. Because fetal partial oxygen pressures are closer to 20 torr, 42 21% O 2 is hyperoxic for fetal cardiomyocytes. This may alter underlying gene expression patterns because normal oxygen levels in fetal hearts are significantly lower. Interestingly, we found that exposure to 21%, 10.5%, and 3% O 2 had no significantly different effects on PKC expression in H9c2 cells. Although the potential effect of "hyperoxia" on fetal cardiomyocytes remains to be further investigated, the finding that 1% O 2 downregulated PKC expression suggests modification in gene expression patterns as a mode of adaptation to oxygen Figure 8 . Effect of PKC activation on cardiac ischemia and reperfusion injury. Hearts were isolated from 3-month-old male offspring that had been exposed to normoxia (control) or hypoxia before birth and were treated in the absence or presence of the PKC activator -RACK (0.5 mol/L) for 10 minutes before subjecting to 20 minutes of ischemia and 30 minutes of reperfusion in a Langendorff preparation. Postischemic recovery of left ventricular developed pressure (LVDP) and end-diastolic pressure (LVEDP) were determined. Lactate dehydrogenase (LDH) release over 30 minutes of reperfusion was measured as area under the curve (AUC). Data are meansϮSEM. *PϽ0.05, hypoxia vs control; †PϽ0.05, ϩ-RACK vs Ϫ-RACK. nϭ5. insufficiency in cardiomyocytes. This is in agreement with many previous studies in which hypoxic effects were investigated in H9c2 cells under 1% O 2 . 37, 38, 43, 44 The finding of similar pattern of increased methylation of the 2 SP1 binding sites at the PKC promoter between H9c2 cells and the fetal hearts of maternal hypoxic treatment provides further evidence supporting the model of H9c2 cells in the present study. Whereas the differences in methylation patterns in the putative Egr1 and MTF1 (Ϫ168) binding sites observed in fetal hearts and H9c2 cells are intriguing, the functional significance of this finding is not clear given that deletions of the regions containing the Egr1 and MTF1 (Ϫ168) sites had no significant effects on the PKC promoter activity. 25 In contrast, deletion of the confirmed binding sites for both SP1 (Ϫ346) and SP1 (Ϫ268) significantly decreased the PKC promoter activity in H9c2 cells. 25 In the present study, we demonstrated by EMSA that methylation of CpG dinucleotides at the core of both SP1 binding sites abolished SP1 binding in H9c2 cells. Previous studies with site-directed methylation of PKC promoter-luciferase constructs selectively at SP1 binding sites at Ϫ268 and Ϫ346 demonstrated that mutation of C m G at either SP1 site Ϫ268 or Ϫ346 alone had no significant effect on the promoter activity, but mutation of C m G at the both SP1 binding sites significantly reduced the promoter activity in H9c2 cells. 24 Although increases in nuclear SP1 protein abundance in hypoxic H9c2 cells may serve as a compensatory mechanism, this increase is relatively ineffective because increased methylation of SP1 binding sites caused an even more significant decrease in SP1 binding to the PKC promoter in the intact chromatin as demonstrated by ChIP assays. The finding that SP1 abundance was not significantly affected by hypoxia in fetal hearts, as well as in the hearts of either male or female adult offspring, together with the finding that hypoxia had no significant effect on SP1 binding affinity in H9c2 cells, fetal and adult hearts, reinforces a primary role of methylation in programming of PKC gene repression.
The causal effect of increased methylation in hypoxiainduced PKC gene repression was further demonstrated with a DNA methylation inhibitor 5-aza-2Ј-deoxycytodine in the present study. 5-Aza-2Ј-deoxycytodine binds to DNA methyltransferase 1, causing its depletion and preventing DNA methylation, 45 and has been widely used to inhibit DNA methylation. 46 -49 In the present study, we demonstrated that 5-aza-2Ј-deoxycytodine concentration-dependently inhibited hypoxia-induced downregulation of PKC mRNA expression. This is caused by inhibition of the hypoxia-induced methylation of both SP1 binding sites resulting in recovered SP1 binding to the PKC promoter in the intact chromatin. Whereas the study of 5-aza-2Ј-deoxycytodine in H9c2 cells is limited, relatively high concentrations of 5-aza-cytidine (a close derivative of 5-aza-2-deoxycytidine) have been shown to rescue luciferase activity in transfected H9c2 cells in excess of 250 mol/L, 50 which may reflect cell-type specific response to 5-aza-2-deoxycytidine and derivatives. The ability of 5-aza-2-deoxycytidine to restore PKC mRNA and protein expression in cardiomyocytes in the presence of a stressor is consistent with earlier studies that showed that 5-aza-2-deoxycytidine blocked cocaine-mediated repression of PKC expression in fetal rat hearts. 24 Previous studies demonstrated that prenatal hypoxia caused an increase in heart susceptibility to ischemia and reperfusion injury in a sex-dependent manner, which was due to fetal programming of PKC gene repression resulting in downregulation of PKC function in the heart of adult male offspring. 14 In the present study, no significant differences were found in SP1 methylation and PKC mRNA abundance between male and female control groups in both fetuses and offspring. This is consistent with the previous findings of no significant difference in PKC protein abundance in the heart between control males and females. 14, 51 However, the sex differences in hypoxia-induced changes in methylation of the SP1 binding sites and PKC transcription were demonstrated in both fetal and offspring hearts. The finding that the hypoxia-induced methylation was significantly greater in the hearts of male fetuses is intriguing given that male and female fetuses are likely exposed to the similar concentrations of steroid hormones in utero. Whereas the mechanisms are not clear at present, the sex difference observed may be caused in part by the greater expression of ER␣ and ER␤ in the hearts of female fetuses. The finding that both ER␣ and ER␤ interacted with the SP1 binding sites at the PKC promoter in intact chromatin in the fetal heart suggests a possible mechanism for the increased protection of SP1 binding sites and PKC transcription in the female hearts in response to hypoxic stress. It has been demonstrated that both ER␣ and ER␤ can activate transcription of the retinoic acid receptor ␣1 gene by the formation of an ER-SP1 complex on the SP1 sites in the retinoic acid receptor ␣1 promoter. 52 It is not clear at present whether the presence of phytoestrogens in the diet of soy-based chows used in the present study might contribute to the sex difference, though the pregnancy is a stage of high estrogen concentrations. This remains as an intriguing area for the future investigation using a casein-based diet. The similar pattern of sex differences in the hypoxia-induced SP1 methylation and PKC transcription demonstrated in the hearts of male and female offspring supports the notion that fetal hypoxia-induced methylation of CpG dinucleotides at the PKC promoter contributes to PKC gene repression in the heart of adult offspring.
The present investigation provides evidence of a novel mechanism of methylation in non-CpG island, sequencespecific transcription factor binding sites in subtle epigenetic modifications of gene expression pattern in fetal programming of cardiac function in response to adverse intrauterine environment. Although it may be difficult to translate the present findings directly into the humans, the possibility that fetal hypoxia may result in programming of a specific gene in the offspring with a consequence of increased cardiac vulnerability provides a mechanistic understanding worthy of investigation in humans. This is because hypoxia is one of the most important and clinically relevant stresses to the fetus and because large epidemiological studies indicate a link between in utero adverse stimuli during gestation and an increased risk of ischemic heart disease in the adulthood.
Novelty and Significance
What Is Known?
• Adverse intrauterine environment increases the risk of hypertension and ischemic heart disease in adulthood.
• Protein kinase C epsilon (PKC) plays a pivotal role of cardioprotection against ischemia and reperfusion injury.
• Fetal hypoxia decreases PKC gene expression in the heart and increases cardiac vulnerability to ischemic injury in adult male offspring in rats.
What New Information Does This Article Contribute?
• Fetal hypoxia causes an epigenetic modification of increased DNA methylation patterns within the PKC gene promoter, resulting in a repression of PKC gene expression in the heart of male rats.
• Decreased PKC protein expression results in increased cardiac vulnerability to ischemic injury in male offspring.
• The sex-dependent difference in epigenetic modification of PKC gene expression patterns occurs during fetal development, as a result of the different expression patterns of estrogen receptors in male and female fetal hearts.
Intrauterine stress is associated with an increased risk of ischemic heart disease in later life. Previous studies in rats showed that fetal hypoxia results in decreased PKC expression and increased cardiac ischemic injury in male offspring. In this study, we found that hypoxia caused increased DNA methylation within the PKC gene promoter, resulting in a repression of PKC gene expression in the hearts of male fetal rats. This epigenetic modification pattern persisted into adulthood. We further demonstrated a causal role of decreased PKC expression in increased heart ischemic vulnerability. Higher levels of estrogen receptors were found in the female fetal hearts, which may protect females from epigenetic modifications caused by intrauterine stress. This study is the first to show that hypoxia alters the epigenetic signature of a cardioprotective gene in utero, and that this modification can persist throughout life, leading to increased susceptibility to ischemia and reperfusion injury in the heart. Together, these findings provide a novel mechanism for hypoxia-induced programming of cardiovascular disease. Because hypoxia is a common stress to the fetus, this study may lead to further inquiries into the molecular adaptations in other tissues that promote pathophysiological conditions in adults.
and stabilizers. We used the following RT-PCR protocol: 42 °C for 30 minutes, 95 °C for 15 minutes, followed by 40 cycles of 95 °C for 15 seconds, 60 °C for 20 seconds, 72 °C for 10 seconds. B2M was used as an internal reference and serial dilutions of the positive control was performed on each plate to create a standard curve. PCR was performed in triplicate, and threshold cycle numbers were averaged.
Quantitative methylation-specific PCR. DNA was isolated from hearts or H9c2 cells using a GenElute Mammalian Genomic DNA Mini-Prep kit (Sigma), denatured with 2 N NaOH at 42 °C for 15 minutes, and treated with sodium bisulfite at 55 °C for 16 hours, as previously described. 3 DNA was purified with a Wizard DNA clean up system (Promega) and resuspended in 120 µl of H 2 O. Bisulfite-treated DNA was used as a template for real-time fluorogenic methylation-specific PCR (MSP) using primers created to amplify promoter binding sites containing possible methylation sites based on the previous sequencing of rat PKCε promoter. 3 GAPDH was used as an internal reference gene. Real-time MSP was performed using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were collected from hearts or H9c2 cells using NXTRACT CelLytic Nuclear Extraction Kit (Sigma). The oligonucleotide probes with CpG and m CpG at the two SP1 binding sites (-346 and -268) in rat PKC promoter region were labeled and subjected to gel shift assays using the Biotin 3′ end labeling kit and LightShift Chemiluminescent EMSA Kit (Pierce Biotechnology, Rockford, IL), as previously described. 3 Briefly, single stranded oligos were incubated with Terminal Deoxynucleotidyl Transferase (TdT) and Biotin-11-dUTP in binding mixture for 30 minutes at 37 ºC. The TdT adds a biotin labeled dUTP to the 3'-end of the oligonucleotides. The oligos were extracted using chloroform and isoamyl alcohol to remove the enzyme and unincorporated biotin-11-dUTP.
Dot blots were performed to ensure the oligos were labeled equally. Combining sense and antisense oligos and exposing to 95ºC for 5 minutes was done to anneal complementary oligos. The labeled oligonucleotides were then incubated with or without nuclear extracts in the binding buffer (from LightShift kit). Binding reactions were performed in 20 μl containing 50 fmol oligonucleotieds probes, 1× binding buffer, 1 μg of poly(dIdC), and 5 μg of nuclear extracts. For competitions studies, increasing concentrations of non-labeled oligonucleotides were added to binding reactions. The samples were then run on a native 5% polyacrylamide gel. The contents of the gel were then transferred to a nylon membrane (Pierce) and crosslinked to the membrane using a UV crosslinker (125 mJoules/cm 2 ). Membranes were blocked and then visualized using the reagents provided in the LightShift kit.
Chromatin immunoprecipitation (ChIP)
Chromatin extracts were prepared from hearts or H9c2 cells. ChIP assays were performed using the ChIP-IT kit (Active Motif), as previously described. 3 Briefly, cells were exposed to 1% formaldehyde for 10 minutes to crosslink and maintain DNA/protein interactions. After the reactions were stopped with glycine, cells were washed, chromatin isolated and the DNA sheared into medium fragments (100 -1000 base pairs) using a sonicator. ChIP reactions were performed using SP1 antibody or ERα and ERβ antibodies to precipitate the transcription factor/DNA complex. Crosslinking was then reversed using a salt solution and proteins digested with proteinase K. Two sets of primers flanking the two SP1 binding sites at -346 and -268 were used: 5′-accatttcctctcgacatgc-3′ (forward) and 5′-agatttcaacccggatcctc-3′ (reverse); 5′-agaggatccgggttgaaatc-3′ (forward) and 5′-ctcacctacctttccgaaaca-3′ (reverse). PCR amplification products were visualized on 2% agarose gel stained with ethidium bromide. To quantify PCR amplification, 45 cycles of real-time PCR were carried out with 3 minutes initial denaturation followed by 95 °C for 30 seconds, 59 °C for 30 seconds, and 72 °C for 30 seconds, using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad).
Hearts subjected to ischemia and reperfusion
Hearts of 3 months old male offspring were isolated and retrogradely perfused via the aorta in a modified Langendorff apparatus, as previously described. 1 After the baseline recording, hearts were subjected to 20 minutes of global ischemia, followed by 30 minutes of reperfusion in the absence or presence of a PKCε activator peptide ψ-εRACK (0.5 μM, KAE-1, KAI Pharmaceuticals) for 10 minutes before ischemia and throughout the period of ischemia and reperfusion, as previously described. 5 Left ventricular developed pressure (LVDP), heart rate (HR), dP/dt max , dP/dt min , and LV end diastolic pressure (LVEDP) were continuously recorded. Lactate dehydrogenase (LDH) activity was measured in coronary effluent collected at 30 seconds before the onset of ischemia, and at 0, 1, 2, 3, 4, 5, 10, 15, 20, and 30 minutes of reperfusion. LDH activity was measured using a standard TOX 7 assay kit (Sigma) and expressed as area under curve (AUC).
Statistical analysis
Data are expressed as mean ± SEM. Statistical significance (P < 0.05) was determined by analysis of variance (ANOVA) followed by Neuman-Keuls post hoc testing or Student's t test, where appropriate. Hearts were isolated from 3-month-old male offspring that had been exposed to normoxia (control) or hypoxia before birth, and were treated in the absence or presence of the PKCε activator ψ-εRACK (0.5 μM) for 10 min before subjecting to 20 min of ischemia and 30 min of reperfusion in a Langendorff preparation. HR, heart rate; LVDP, left ventricular developed pressure; LVEDP, left ventricular end diastolic pressure; dP/dt max , maximal rate of contraction; dP/dt min , maximal rate of relaxation; CF, coronary flow. n = 5.
Online
Online Figure I . Effect of hypoxia on SP1 abundance. Pregnant rats were treated with hypoxia, and hearts were isolated from near-term fetuses and 3 months old offspring. M, male; F, female. H9c2 cells were treated with 1% O 2 (hypoxia) vs. 21% O 2 (control) for 24 hours. SP1 protein abundance was determined in nuclear extracts. Date are mean ± SEM. * P < 0.05 vs. control (n = 5-8). Online Figure III . Effect of PKCε activation on cardiac ischemia and reperfusion injury. Hearts were isolated from 3 months old male offspring that had been exposed to normoxia (control) or hypoxia before birth, and were treated in the absence or presence of the PKCε activator ψ-εRACK (0.5 μM) for 10 minutes before subjecting to 20 minutes of ischemia and 30 minutes of reperfusion in a Langendorff preparation. Post-ischemic recovery of dP/dt max and dP/dt min were determined. Data are mean ± SEM. * P < 0.05, hypoxia vs. control; † P < 0.05, + ψ-εRACK vs. -ψ-εRACK. n = 5. 
